Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-31

FDA Approved: RYVENT — Original Application (Carwin Pharmaceutical Associates, LLC)

View source ↗

Summary

FDA approved Ryvent (carbinoxamine maleate) in relation to its original application for this generic antihistamine from Carwin Pharmaceutical Associates, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RYVENT (carbinoxamine maleate)

Snippet

ORIG AP for RYVENT (CARBINOXAMINE MALEATE)